Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genentech
4
×
life sciences
national blog main
national top stories
roche
4
×
san francisco top stories
boston blog main
boston top stories
eli lilly
novartis
san francisco blog main
avapritinib
biogen
blueprint medicines
boston
cancer
clinical trials
deals
drug prices
europe top stories
fda
indiana blog main
indiana top stories
investing
medullary thyroid cancer
national
new york top stories
non-small cell lung cancer
pralsetinib
selpercatinib
spinal muscular atrophy
thyroid cancer
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
What
drug
4
×
fda
approval
blueprint
cancer
latest
medicines
ret
roche
therapy
address
alzheimer’s
approved
approves
atrophy
bio
candidate
carries
certain
companies
currently
daily
designed
different
evrysdi
fail
friday
gene
genetic
green
home
increases
intended
lights
liquid
marketing
medicine
muscle
muscular
new
Language
unset
Current search:
roche
×
drug
×
genentech
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More